Dr. Willmar Schwabe GmbH & Co. KG, commonly known as Schwabe, is a leading player in the herbal medicine industry, headquartered in Karlsruhe, Germany. Founded in 1866, the company has established a strong presence in Europe and beyond, focusing on the development and production of high-quality phytopharmaceuticals. Schwabe is renowned for its innovative approach to herbal remedies, offering a diverse range of products that combine traditional knowledge with modern scientific research. Their core offerings include herbal extracts, dietary supplements, and over-the-counter medications, all distinguished by rigorous quality standards and efficacy. With a commitment to sustainability and a robust portfolio of patented formulations, Schwabe has secured a prominent market position, recognised for its contributions to the field of herbal medicine. The company continues to lead the way in advancing phytotherapy, making significant strides in both research and product development.
How does Dr. Willmar Schwabe GmbH & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dr. Willmar Schwabe GmbH & Co. KG's score of 13 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Dr. Willmar Schwabe GmbH & Co. KG reported a significant reduction in carbon emissions, achieving a decrease of approximately 6,800,000 kg CO2e compared to 2021 levels. For the year 2022, the company disclosed emissions of about 6,690,000 kg CO2e for Scope 1 and 2 combined. The total emissions for 2021 were reported at approximately 48,284,000 kg CO2e, which included 22,629 kg CO2e from Scope 1 and 25,565 kg CO2e from Scope 2. Despite these figures, there are currently no specific reduction targets or commitments outlined by the company, nor are there any emissions data cascaded from a parent or related organization. Dr. Willmar Schwabe GmbH & Co. KG is actively working towards enhancing its sustainability practices, although detailed climate pledges or SBTi targets have not been specified. The company continues to focus on reducing its carbon footprint and improving energy efficiency as part of its broader environmental strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 22,629 | - |
| Scope 2 | 25,565 | - |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dr. Willmar Schwabe GmbH & Co. KG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
